Technology, Consumer Discretionary, Healthcare Aug 05, 2021 04:52 PM (GMT+8) · EqualOcean
Hengrui pharmaceutical announced that the company has recently received the approval notice of drug clinical trial on hr19003 patch approved and issued by the State Drug Administration, and will carry out clinical trial in the near future. The drug can penetrate the skin around the peripheral nerve of the drug site, block the sodium ion channel on the nerve cell membrane, inhibit the sodium ion from flowing into the nerve fiber cell membrane, block nerve excitation and conduction, and produce reversible local block, so as to achieve the effect of analgesia and anesthesia.

This text is a result of machine translation.

Related companies：